DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS






Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





 Company News
National Cancer Institute Release: Raising Awareness About Cancer Clinical Trials In Multicultural Communities 2/19/2015 9:15:40 AM
UT Southwestern Medical Center Receives Key National Cancer Institute Funding To Plan First U.S. Center For Heavy Ion Radiation Therapy Research 2/11/2015 11:10:25 AM
Genalyte Inc. Completes First Phase Of National Cancer Institute Grant Program 1/28/2015 10:09:26 AM
Lion Biotechnologies, Inc. Amends CRADA With National Cancer Institute To Develop TIL Therapy For Additional Cancer Indications 1/26/2015 7:44:01 AM
MedImmune (AZN) Establishes Three-Year Partnership With National Cancer Institute To Advance Oncology Research 1/21/2015 9:32:53 AM
The Pancreatic Cancer Action Network And The National Cancer Institute's Frederick National Laboratory For Cancer Research Join Forces For Research Initiative 1/12/2015 8:59:13 AM
Corvida Medical Launches Research Study With Funding And Support From The National Cancer Institute 12/5/2014 11:16:21 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014 3:38:49 PM
12345678910...